Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pfizer collaboration to provide access to contraceptives in poorer nations

Pfizer collaboration to provide access to contraceptives in poorer nations

9th May 2017

Pfizer has expanded a collaborative project to help provide greater access to contraceptives in some of the world's poorest countries.

The company has announced a multi-year extension of its work with the Bill and Melinda Gates Foundation and the Children's Investment Fund Foundation to further broaden access to Pfizer's all-in-one injectable contraceptive Sayana Press.

It will now be available to qualified purchasers at a guaranteed price of $0.85 (66p) per dose, a reduction from the previous price of $1. Based on a prefilled single-use system, it eliminates the need to prepare a needle and syringe, allowing it to be administered outside clinical settings.

John Young, president of Pfizer Essential Health, said: "Our hope is that more women in the developing world will now have access to Sayana Press as an option to meet their specific family planning needs."

This collaboration launched in 2014, with 6.4 million units of Sayana Press shipped to 20 developing countries by the end of 2016. The product is expected to have reached more than 1.5 million women – up from 350,000 women at the end of 2014.

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801835601-ADNFCR

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.